Ardelyx Inc

ARDXNASDAQ · USD
3.44USD+0.02 (+0.59%)
442

Ardelyx Inc (ARDX) Option Chain

As of September 18, 2026, Ardelyx Inc is trading at $3.44, a +0.59% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 271.0%. IV Rank is 99%.

Read more

Tracking the ARDX option chain helps you see every strike and expiry on Ardelyx Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Ardelyx Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ARDX options activity at a glance. Use our scanner to monitor the ARDX option chain in real time and filter for the ARDX options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ARDX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the ARDX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where ARDX stock options are being actively traded and where they are not.

Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult patients with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia. It is also developing RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease; and RDX020, an early-stage program in metabolic acidosis, a serious electrolyte disorder in patients with CKD.

The company has agreements with Kyowa Kirin in Japan, Fosun Pharmaceutical Industrial Development Co. Ltd. in China, and Knight Therapeutics, Inc. in Canada for the development and commercialization of tenapanor in their respective territories. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Ardelyx Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen ARDX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of ARDX stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile98.81% Elevated
  • Market cap (M$)852
  • 52 weeks high-59.29%
  • 52 weeks low2.70%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$12.90
    275.00% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-10-29
  • P/E
  • Future P/E13.17
  • EPS (ttm)-0.23
  • EPS growth next 5 years

As of September 18, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
9.757240.142.442.352.801.00-70.761.750.001.750290.25
35.974000.861.441.003.602.00-41.520.750.000.7502064.03
57.4945430.040.440.400.553.00-12.280.100.000.100342.51
71.83415260.080.000.050.104.00+16.960.550.750.560.09220,38428.17
81.041,16000.080.000.050.105.00+46.200.052.201.56-0.44016318.96

As of September 18, 2026

Scan the full option chain in one place

Browse the full ARDX option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial